427
Participants
Start Date
February 16, 2021
Primary Completion Date
March 4, 2022
Study Completion Date
March 10, 2022
Fluticasone propionate/salmeterol (FS)
FS administered via electronic multidose dry powder inhaler (eMDPI) Digital System (DS) with component devices including smart device application (App), Digital Health Platform (DHP), and provider-facing dashboard
Albuterol
Albuterol administered via electronic multidose dry powder inhaler (eMDPI) Digital System (DS) with component devices including smart device application (App), Digital Health Platform (DHP), and provider-facing dashboard
Standard of Care Asthma Medication
Current inhaled corticosteroid(ICS)/Long-acting beta agonist(LABA) and any additional controller medication for asthma
Standard of Care Rescue Medication
Current rescue medication
Teva Investigational Site 14956, Hollis
Teva Investigational Site 14967, Pittsburgh
Teva Investigational Site 14983, White Marsh
Teva Investigational Site 14954, Gastonia
Teva Investigational Site 14989, North Charleston
Teva Investigational Site 14942, Savannah
Teva Investigational Site 14984, Hialeah
Teva Investigational Site 14960, Miami Lakes
Teva Investigational Site 14979, Hialeah
Teva Investigational Site 14953, Miami
Teva Investigational Site 14944, Miami
Teva Investigational Site 14943, Aventura
Teva Investigational Site 14978, Cutler Bay
Teva Investigational Site 14970, Miami
Teva Investigational Site 14955, Fort Lauderdale
Teva Investigational Site 14969, Boynton Beach
Teva Investigational Site 14981, Sarasota
Teva Investigational Site 14950, Lexington
Teva Investigational Site 14949, Owensboro
Teva Investigational Site 14968, Toledo
Teva Investigational Site 14941, Cincinnati
Teva Investigational Site 14964, Farmington Hills
Teva Investigational Site 14961, Glenview
Teva Investigational Site 14972, Springfield
Teva Investigational Site 14977, Lincoln
Teva Investigational Site 14952, Oklahoma City
Teva Investigational Site 14958, Oklahoma City
Teva Investigational Site 14948, Waco
Teva Investigational Site 14963, Houston
Teva Investigational Site 14985, Boerne
Teva Investigational Site 14962, Wheat Ridge
Teva Investigational Site 14966, Colorado Springs
Teva Investigational Site 14947, Boise
Teva Investigational Site 14987, Draper
Teva Investigational Site 14965, Murray
Teva Investigational Site 14971, Phoenix
Teva Investigational Site 14982, Los Angeles
Teva Investigational Site 14945, San Diego
Teva Investigational Site 14946, San Diego
Teva Investigational Site 14974, Fountain Valley
Teva Investigational Site 14975, Miami
Teva Investigational Site 14951, Tallahassee
Teva Investigational Site 14976, Bangor
Teva Investigational Site 14990, Bellevue
Teva Investigational Site 14957, Toms River
Teva Investigational Site 14988, Providence
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY